Hematopoietic and Lymphoid Cell NeoplasmNCT05038384
Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work
An observational study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
- What is being tested?
- Survey Administration
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Dec 2020to 30 Mar 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine at M D Anderson Cancer Center
Who may be able to join
- Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine. This includes physicians, advanced practice providers (APPs), and other clinical staff in the Supportive Care Center and Acute Palliative Care Unit
Who cannot join
- No
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work Survey
This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook.
Read the detailed description
PRIMARY OBJECTIVES:
- To explore the global perception of the perceived usefulness of the handbook, and the frequency that the handbook is consulted.
II. To explore the perceived usefulness of and adherence to each individual item of the handbook.
III. To solicit personnel for their ideas about the handbook, and particularly any additional handbook items they might suggest.
IV. To explore any relationships between the actual use or the perceived importance of each handbook item with respondents' self-reported professional satisfaction.
- To explore any associations between responses to handbook items and professional, demographic, and work satisfaction characteristics before and during the coronavirus disease 2019 (COVID-19) crisis.
VI. To explore respondents' global perceptions of the usefulness and adherence to the handbook before and during the COVID-19 crisis.
OUTLINE:
Participants complete a survey over 20 minutes.
- Being tested
- Survey Administration
- Medical subject headings
- Hematologic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey AdministrationOther
Complete survey
| Study group | Role | What they receive |
|---|---|---|
| Observational (survey) | Participants complete a survey over 20 minutes. Receives: Other: Survey Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Global perception of usefulness
Will be assessed by survey question E, which has five options: very useful, useful, neither useful nor useless, useless and very useless. The main interest is the proportion of responders who select very useful and useful.
Measured: through study completion, an average of 1 year
Frequency of consultation
Will be assessed by survey question D, which has five options: never, once a month or less, a few times a month, a few times a week and daily. The main interest is the proportion of responders who select daily and a few times a week.
Measured: through study completion, an average of 1 year
Perceived usefulness of individual items
Will be assessed by survey question F 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.
Measured: through study completion, an average of 1 year
Adherence to individual items
Will be assessed by survey question G 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.
Measured: through study completion, an average of 1 year
Personal ideas about the handbook
Will be collected by survey question I and question J. Comments and suggestions will be collected and used to aggregate opinions toward handbook improvement.
Measured: through study completion, an average of 1 year
Responders' self-reported professional satisfaction
Will be assessed by survey question K, L1, and L3. Association between the perceived usefulness and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.
Measured: through study completion, an average of 1 year
Responders' profession
Will be summarized by survey question A, and responders' demographics will be summarized by survey question B and C. Responders' work satisfaction after coronavirus disease 2019 (COVID-19) will be examined by survey question L2 and L4. Association between the perceived usefulness and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.
Measured: through study completion, an average of 1 year
Responders' global perceptions of usefulness and adherence to the handbook during COVID-19
Will be assessed by survey question M, N and O, and frequency and proportion will be used to summarize the results.
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2021
- Study start3 Dec 2020
- Primary completion30 Mar 2023
- Study completion30 Mar 2023
Why it stopped: Accrual Limit
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hematopoietic and Lymphoid Cell NeoplasmStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Patricia Bramati, MD, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05038384
- Sponsor's protocol ID
- 2020-0792
- Other IDs
- NCI-2021-08920, 2020-0792
- Status last verified
- Mar 2023
- First submitted
- 24 Aug 2021
- Last updated
- 31 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work Survey
- ClinicalTrials.gov ID
- NCT05038384
- Acronym / sponsor ID
- 2020-0792
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Accrual Limit
- Enrolment
- 0 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- 3 Dec 2020 (actual)
- Primary completion
- 30 Mar 2023 (actual)
- Study completion
- 30 Mar 2023 (actual)
- First posted
- 9 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook.
Detailed description
PRIMARY OBJECTIVES:
- To explore the global perception of the perceived usefulness of the handbook, and the frequency that the handbook is consulted.
II. To explore the perceived usefulness of and adherence to each individual item of the handbook.
III. To solicit personnel for their ideas about the handbook, and particularly any additional handbook items they might suggest.
IV. To explore any relationships between the actual use or the perceived importance of each handbook item with respondents' self-reported professional satisfaction.
- To explore any associations between responses to handbook items and professional, demographic, and work satisfaction characteristics before and during the coronavirus disease 2019 (COVID-19) crisis.
VI. To explore respondents' global perceptions of the usefulness and adherence to the handbook before and during the COVID-19 crisis.
OUTLINE:
Participants complete a survey over 20 minutes.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Observational (survey) | – | Other: Survey AdministrationParticipants complete a survey over 20 minutes. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine at M D Anderson Cancer Center
Key inclusion criteria (1 listed)
- Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine. This includes physicians, advanced practice providers (APPs), and other clinical staff in the Supportive Care Center and Acute Palliative Care Unit
Key exclusion criteria (1 listed)
- No
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey AdministrationComplete survey | Other | Observational (survey) |
Primary outcome
Global perception of usefulness
Time frame: through study completion, an average of 1 year
Will be assessed by survey question E, which has five options: very useful, useful, neither useful nor useless, useless and very useless. The main interest is the proportion of responders who select very useful and useful.
Frequency of consultation
Time frame: through study completion, an average of 1 year
Will be assessed by survey question D, which has five options: never, once a month or less, a few times a month, a few times a week and daily. The main interest is the proportion of responders who select daily and a few times a week.
Perceived usefulness of individual items
Time frame: through study completion, an average of 1 year
Will be assessed by survey question F 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.
Adherence to individual items
Time frame: through study completion, an average of 1 year
Will be assessed by survey question G 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.
Personal ideas about the handbook
Time frame: through study completion, an average of 1 year
Will be collected by survey question I and question J. Comments and suggestions will be collected and used to aggregate opinions toward handbook improvement.
Responders' self-reported professional satisfaction
Time frame: through study completion, an average of 1 year
Will be assessed by survey question K, L1, and L3. Association between the perceived usefulness and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.
Responders' profession
Time frame: through study completion, an average of 1 year
Will be summarized by survey question A, and responders' demographics will be summarized by survey question B and C. Responders' work satisfaction after coronavirus disease 2019 (COVID-19) will be examined by survey question L2 and L4. Association between the perceived usefulness and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.
Responders' global perceptions of usefulness and adherence to the handbook during COVID-19
Time frame: through study completion, an average of 1 year
Will be assessed by survey question M, N and O, and frequency and proportion will be used to summarize the results.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2023.
- MD Anderson Cancer CenterLink provided by the sponsor.
Related trials for Hematopoietic and Lymphoid Cell Neoplasm
Not yet recruitingPhase 4
MACE and BTK Inhibitors
Hematologic Cancer, MACE
Recruiting
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Solid Tumor, Adult, Solid Tumor, Childhood
Active, not recruitingPhase 2
Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
Active, not recruitingPhase 2
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Patricia Bramati, MD principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Global perception of usefulness (time frame: through study completion, an average of 1 year). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023.